moxestrol has been researched along with Uterine-Neoplasms* in 2 studies
2 other study(ies) available for moxestrol and Uterine-Neoplasms
Article | Year |
---|---|
Visualization by light and scanning electron microscopy of reproductive tract lesions in female mice treated transplacentally with diethylstilbestrol.
Pregnant female mice were exposed to diethylstilbestrol or 11 beta-methoxy-17 beta-estradiol on Days 9 to 16 of gestation. The female offspring of these animals were then examined for reproductive tract abnormalities. Scanning electron microscopic and histological evaluation of these specimens demonstrated reproductive tract lesions in all treatment groups when compared to matched control mice. These lesions included apparent displacement of the squamocolumnar junction, uterine squamous metaplasia, atypical uterine cell surface specializations, protrusions of uterine cells, vaginal and cervical papillary growths, enlarged uterine cervix, abnormal vaginal and uterine folding patterns, female hypospadias, and the presence of vaginal concretions. Scanning electron microscopic observations proved particularly useful in studying lesions which involved the disruption of the normal structure and shape of the reproductive tract and the displacement of cell types. Topics: Animals; Diethylstilbestrol; Estradiol Congeners; Ethinyl Estradiol; Female; Genital Diseases, Female; Maternal-Fetal Exchange; Mice; Microscopy, Electron; Microscopy, Electron, Scanning; Pregnancy; Uterine Cervical Diseases; Uterine Neoplasms; Vaginal Diseases | 1981 |
11beta-Methoxy-17-ethynyl-1,3,5(10)-estratriene-3,17beta-diol (moxestrol), a tag for estrogen receptor binding sites in human tissues.
Topics: Binding Sites; Binding, Competitive; Breast Neoplasms; Centrifugation, Density Gradient; Cytoplasm; Estradiol; Ethinyl Estradiol; Female; Humans; Methods; Receptors, Estrogen; Uterine Neoplasms | 1978 |